These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 19457860)

  • 1. Interferon-lambda is functionally an interferon but structurally related to the interleukin-10 family.
    Gad HH; Dellgren C; Hamming OJ; Vends S; Paludan SR; Hartmann R
    J Biol Chem; 2009 Jul; 284(31):20869-75. PubMed ID: 19457860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling.
    Dumoutier L; Tounsi A; Michiels T; Sommereyns C; Kotenko SV; Renauld JC
    J Biol Chem; 2004 Jul; 279(31):32269-74. PubMed ID: 15166220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structure of human interferon lambda and what it has taught us.
    Gad HH; Hamming OJ; Hartmann R
    J Interferon Cytokine Res; 2010 Aug; 30(8):565-71. PubMed ID: 20712454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-λ4 inhibits HIV infection of macrophages through signalling of IFN-λR1/IL-10R2 receptor complex.
    Su QJ; Wang X; Zhou RH; Guo L; Liu H; Li JL; Ho WZ
    Scand J Immunol; 2018 Nov; 88(5):e12717. PubMed ID: 30247785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of human interferon-λ1 in complex with its high-affinity receptor interferon-λR1.
    Miknis ZJ; Magracheva E; Li W; Zdanov A; Kotenko SV; Wlodawer A
    J Mol Biol; 2010 Dec; 404(4):650-64. PubMed ID: 20934432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human interferon-lambda3 is a potent member of the type III interferon family.
    Dellgren C; Gad HH; Hamming OJ; Melchjorsen J; Hartmann R
    Genes Immun; 2009 Mar; 10(2):125-31. PubMed ID: 18987645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel method for detection of IFN-lambda 3 binding to cells for quantifying IFN-lambda receptor expression.
    Santer DM; Minty GES; Mohamed A; Baldwin L; Bhat R; Joyce M; Egli A; Tyrrell DLJ; Houghton M
    J Immunol Methods; 2017 Jun; 445():15-22. PubMed ID: 28274837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ran binding protein 9 (RanBPM) binds IFN-λR1 in the IFN-λ signaling pathway.
    Zhang J; Cong X; Zhaoqiao J; Yang X; Li M; Chen H; Mi R; Jin G; Liu F; Huang BR
    Sci China Life Sci; 2017 Sep; 60(9):1030-1039. PubMed ID: 28547582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parainfluenza Virus 3 Blocks Antiviral Mediators Downstream of the Interferon Lambda Receptor by Modulating Stat1 Phosphorylation.
    Eberle KC; McGill JL; Reinhardt TA; Sacco RE
    J Virol; 2015 Dec; 90(6):2948-58. PubMed ID: 26719274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analysis of cytokines comprising the IL-10 family.
    Zdanov A
    Cytokine Growth Factor Rev; 2010 Oct; 21(5):325-30. PubMed ID: 20846897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex.
    Kotenko SV; Gallagher G; Baurin VV; Lewis-Antes A; Shen M; Shah NK; Langer JA; Sheikh F; Dickensheets H; Donnelly RP
    Nat Immunol; 2003 Jan; 4(1):69-77. PubMed ID: 12483210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain.
    Donnelly RP; Sheikh F; Kotenko SV; Dickensheets H
    J Leukoc Biol; 2004 Aug; 76(2):314-21. PubMed ID: 15123776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo developed protein binders mimicking Interferon lambda signaling.
    Kolářová L; Zahradník J; Huličiak M; Mikulecký P; Peleg Y; Shemesh M; Schreiber G; Schneider B
    FEBS J; 2022 May; 289(9):2672-2684. PubMed ID: 34826176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and establishment of type IV interferon and the characterization of interferon-υ including its class II cytokine receptors IFN-υR1 and IL-10R2.
    Chen SN; Gan Z; Hou J; Yang YC; Huang L; Huang B; Wang S; Nie P
    Nat Commun; 2022 Feb; 13(1):999. PubMed ID: 35194032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-22R, IL-10R2, and IL-22BP binding sites are topologically juxtaposed on adjacent and overlapping surfaces of IL-22.
    Wu PW; Li J; Kodangattil SR; Luxenberg DP; Bennett F; Martino M; Collins M; Dunussi-Joannopoulos K; Gill DS; Wolfman NM; Fouser LA
    J Mol Biol; 2008 Oct; 382(5):1168-83. PubMed ID: 18675824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of IL-22 bound to its high-affinity IL-22R1 chain.
    Jones BC; Logsdon NJ; Walter MR
    Structure; 2008 Sep; 16(9):1333-44. PubMed ID: 18599299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of a soluble decoy receptor IL-22BP bound to interleukin-22.
    de Moura PR; Watanabe L; Bleicher L; Colau D; Dumoutier L; Lemaire MM; Renauld JC; Polikarpov I
    FEBS Lett; 2009 Apr; 583(7):1072-7. PubMed ID: 19285080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of IFN-λ on Epithelial Barrier Function Contribute to Klebsiella pneumoniae ST258 Pneumonia.
    Ahn D; Wickersham M; Riquelme S; Prince A
    Am J Respir Cell Mol Biol; 2019 Feb; 60(2):158-166. PubMed ID: 30183325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex.
    Yoon SI; Logsdon NJ; Sheikh F; Donnelly RP; Walter MR
    J Biol Chem; 2006 Nov; 281(46):35088-96. PubMed ID: 16982608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological activity of interleukins-28 and -29: comparison with type I interferons.
    Meager A; Visvalingam K; Dilger P; Bryan D; Wadhwa M
    Cytokine; 2005 Jul; 31(2):109-18. PubMed ID: 15899585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.